Arsenal Capital Partners announces acquisition of IGM Resins
NEW YORK — The acquisition of IGM Resins, a provider of intermediates to the global ultraviolet ("UV") radiation cure coatings, inks and adhesives industry, was announced by Arsenal Capital Partners, a leading New York-based private equity firm that invests in middle-market specialty industrial and healthcare companies. UV technologies are used in numerous end markets, including printing, packaging, electronics and construction.
Founded in 1999, and headquartered in the Netherlands, IGM Resins is a global specialty chemical company and leading supplier of photoinitiators and acrylates to the worldwide UV curable coatings and inks markets. In 2010, the company acquired the Photomer brand UV Acrylates business from Cognis, providing it with a fully integrated product portfolio, including UV curable monomers, epoxy Acrylates, polyester and polyether Acrylates and Urethane Acrylates.
IGM Resins'' strategy is to expand its product portfolio, services, production, technical support and product development in support of the high growth UV radiation cure market.
The acquisition of IGM is the fourth acquisition by Arsenal Capital in 2012, following investments in Fluoro-Seal Holdings, Plasticolors Inc. and Evonik''s Colorants business. IGM joins Arsenal''s extensive portfolio of investments in the specialty industrials sector.
Arsenal currently has $1.1 billion of committed equity capital.